Latest research
Pipeline Review Market Research Report
Healthcare industry is at a consistent growth since past couple of years. Technological advancements and the betterment of our understanding in anatomy as its effect has widened the horizons of healthcare market. This has had a significant impact on global economy. Global healthcare industry has sustained a 4% compound annual Healthcare industry is at a consistent growth since past couple of years. Technological advancements and the betterment of our understanding in anatomy as its effect has widened the horizons of healthcare market. This has had a significant impact on global economy. Global healthcare industry has sustained a 4% compound annual
The primary objective of these reports is to provide data-driven insights into the health burden, healthcare resources, healthcare infrastructure, healthcare services, and installed base of major medical equipment. These reports can play a critical role in assessing market potential based on healthcare needs and medical device penetration, and in driving strategies aimed at increasing demand for healthcare products.
How Can Our Healthcare Insights Reports Help You?
- Assess market potential
- Prioritize geographies for expansion
- Assess replacement or upgrade opportunities and align product portfolios with the needs of healthcare facilities
- Evaluate the attractiveness of regional healthcare markets, infrastructure readiness, and capital investment opportunities
- Assess total addressable markets (TAM) and evaluate market readiness for new technologies or products
Healthcare Spending
Global healthcare spending reached USD 11.1 trillion in 2024, driven by evolving healthcare needs resulting from population aging and the increasing burden of chronic diseases.
- In the United States, approximately 90% of annual healthcare spending is directed toward people with chronic and mental health conditions.
- The global population aged 60 years and above is expected to reach 2.1 billion by 2050, accounting for 26% of the world's population.
In 2024, healthcare spending accounted for approximately 10.0% of global GDP. While per capita healthcare spending was around USD 1,354 globally, there is a significant disparity between developed and developing countries.
| Per Capita Healthcare Spending | |
|---|---|
| United States | USD 12,740 |
| Japan | USD 3,890 |
| China | USD 675 |
| Indonesia | USD 395 |
| India | USD 102 |
Healthcare Resources
| Number of Physicians per 1,000 Population | |
|---|---|
| High-income countries | 3.7 |
| Middle-income countries | 2.3 |
| Low-income countries | 0.4 |
Healthcare Infrastructure
In terms of healthcare infrastructure, such as hospitals and hospital beds, there is a significant disparity between developed, developing, and least-developed countries, similar to the disparities observed in healthcare spending and healthcare resources.
| Number of Intensive Care Unit Beds per 100,000 Population | |
|---|---|
| High-income countries | 12.8 |
| Middle-income countries | 5.6 |
| Low-income countries | Less than 2.5 |
Scope of Our Healthcare Insights Reports
-
1. Introduction
- 1.1 Research Scope
- 1.2 Research Methodology
- 2. Executive Summary
-
3. Healthcare Spending (2021-2034)
- 3.1 Total Healthcare Spending
- 3.2 Per Capita Healthcare Spending
- 3.3 Healthcare Spending as a Percentage of GDP
- 3.4 Healthcare Spending by Source of Funding
-
4. Healthcare Infrastructure (2025)
- 4.1 Number of Hospitals
- 4.2 Number of Public vs. Private Hospitals
- 4.3 Number of Hospital Beds
- 4.4 Number of Public vs. Private Hospital Beds
- 4.5 Number of Intensive Care Unit Beds
- 4.6 Number of Operating Rooms
- 4.7 Number of Nursing Homes
- 4.8 Number of Nursing Home Beds
- 4.9 Number of Imaging Centers
-
5. Healthcare Resources (2025)
- 5.1 Number of Physicians
- 5.2 Number of Nurses
- 5.3 Number of Cardiologists
- 5.4 Number of Neurologists
- 5.5 Number of Orthopedic Surgeons
- 5.6 Number of Radiologists
- 5.7 Number of Dentists
- 5.8 Number of Pharmacists
-
6. Installed Base of Medical Equipment (2025)
- 6.1 Computed Tomography (CT) Scanners
- 6.2 Magnetic Resonance Imaging (MRI) Systems
- 6.3 Positron Emission Tomography (PET/CT) Systems
- 6.4 Ultrasound Systems
- 6.5 X-ray Systems
- 6.6 Mammography Systems
- 6.7 C-arm Systems
- 6.8 Patient Monitoring Systems
- 6.9 Catheterization Laboratories
- 6.10 Ventilators
- 6.11 Electrocardiography (ECG) Systems
- 6.12 Dialysis Machines
The following countries can be covered within this scope:
- United States
- Canada
- United Kingdom
- Germany
- France
- Italy
- Spain
- Turkey
- Netherlands
- Switzerland
- Poland
- Belgium
- Sweden
- Austria
- China
- Japan
- India
- South Korea
- Australia
- Singapore
- Malaysia
- Indonesia
- Thailand
- New Zealand
- Philippines
- Brazil
- Mexico
- Argentina
- South Africa
- United Arab Emirates
- Saudi Arabia
- More...
We can assess the feasibility of providing this data for specific countries not listed above.
Data Sources
- Interviews with relevant stakeholders at hospitals/healthcare facilities
- Interviews with experts/Key Opinion Leaders (KOLs) with extensive experience in the healthcare market and specialized knowledge of the research scope
- Published reports/data from relevant associations
- Published reports/data from organizations such as the World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), and Eurostat
- Published research articles from organizations such as NCBI, ResearchGate, and others
- Internal data repository – relevant reports, databases, and customized projects
- External databases (free and paid)
- Published reports/data from healthcare facilities/healthcare groups, government health departments, and others
GET IN TOUCH WITH US
Why Epidemiology Report?
The primary objective of epidemiology reports is to provide data-driven insights into the incidence, prevalence, and distribution of diseases across different populations, geographies and time periods. These reports can play a crucial role in the assessment of market potential based on patient populations and drive the strategies for the development for healthcare products such as pharmaceuticals, medical devices, or diagnostics. Epidemiology reports include segmentation by age, gender, region, and disease stage, enabling companies to make informed decisions about market entry, product positioning, and clinical trial planning.
HOW CAN OUR EPIDEMIOLOGY REPORTS HELP YOU?
Assist in the estimation of the potential/addressable market based on patient population
Provide an understanding of the trend in patient population
Provide an overview of the cost of care & therapeutics market
Provide an understanding of the disease landscape
Provide an understanding of the treated patient population
SCOPE OF OUR EPIDEMIOLOGY REPORTS
- Overview of the Disease/Condition
- Total Prevalence of the Disease/Condition, 2019–2032
- Distribution of the Prevalent Cases by Disease Type, Age, Gender, 2024
- Number of Diagnosed Patients of the Disease/Condition, 2019–2032
- Number of Treated Patients of the Disease/Condition, 2019–2032
- Cost of Care for the Disease/Condition, 2024
- Total Therapeutics Market for the Disease/Condition, 2019–2032
We can check the feasibility of adding specific countries to the geographic scope based on your requirements.
USA
UK
Germany
France
Italy
Spain
Japan
China
India
AustraliaGlobally, chronic diseases account for almost three-quarters of all deaths. At present, more than one in three adults have at least one chronic condition. Unhealthy lifestyle and ageing population are some of the main factors contributing to the growing burden of non-communicable diseases such as diabetes and cardiovascular conditions.
- The United Nations Population Fund (UNFPA) has projected that the number of people aged 60 years and above reach around 2.1 billion by 2050 (accounting for around 22% of the global population)
- More than 500 million people globally suffer from cardiovascular diseases
Cost of Chronic Diseases
Management of chronic diseases and treatment of conditions due to these chronic diseases accounts for a significantly large proportion of the total healthcare spending of all countries, developed as well as
In the U.S., around 90% of the annual healthcare spending is on people suffering from chronic and mental conditions.
The World Economic Forum estimates that the global cost of treating chronic diseases will be around USD 30 trillion by 2030.
BURDEN OF CHRONIC DISEASES IN SELECTIVE COUNTRIES (IN MILLION PATIENTS)
| DISEASE INDICATION |
U.S | U.K | Germany | France | Italy | Spain | Saudi Arabia | United Arab Emirates |
|---|---|---|---|---|---|---|---|---|
| Diabetes | 32.5 | 4.0 | 6.2 | 4.0 | 4.5 | 5.2 | 4.4 | 1.0 |
| Hypertension | 148.2 | 23.2 | 30.7 | 22.2 | 25.3 | 15.7 | 15.2 | 5.3 |
| Kidney Stone | 0.67 | 0.30 | 0.38 | 0.29 | 0.26 | 0.27 | 0.13 | 0.03 |
| Obesity | 109.3 | 23.6 | 21.3 | 13.6 | 10.4 | 10.3 | 10.1 | 3.9 |
Cancer Epidemiology
Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. If it is not treated, cancer can invade surrounding tissues and spread to other parts of the body.
Around 20 million new cancer cases are diagnosed every year with men accounting for roughly 51% of them. China, India, USA and Japan account for around 4% of new cancer cases globally.
Cancer Incidence – Top 10 Countries (in million new cases)
China4.8
USA2.4
India1.4
Japan1.0
Russia0.64
Brazil0.63
Germany0.61
France
0.48
UK0.45
Italy0.44
Top 10 Common Cancers (in million new cases)
| Type | Cancer Incidence |
|---|---|
| Trachea, Bronchus & Lung | 2.5 |
| Breast | 2.3 |
| Colorectum | 1.9 |
| Prostate | 1.5 |
| Stomach | 0.97 |
| Liver | 0.87 |
| Thyroid | 0.82 |
| Cervix Uteri | 0.66 |
| Bladder | 0.61 |
| Non-Hodgkin Lymphoma | 0.55 |
Lung Cancer, Breast Cancer, Colorectal Cancer and Prostate Cancer account for around 44% of the new cancer cases (excluding non-melanoma skin cancer).
Diabetes Epidemiology
Diabetes is a chronic medical condition in which the body either doesn't produce enough insulin or can't effectively use the insulin it produces, leading to elevated levels of glucose in the blood. Over time, high blood sugar can cause serious damage to the heart, kidneys, eyes, and nerves.
Around 540 million people suffer from diabetes globally with more than 40% of the cases undiagnosed.
The two main types of diabetes are Type 1 and Type2. Type 1 is an autoimmune condition where the body destroys insulin-producing cells, requiring lifelong insulin therapy whereas Type 2 is a metabolic disorder where the body either doesn't produce enough insulin or cells become resistant to its effects. Type 2 accounts for around 96% of the prevalent diabetes cases.
Diabetes Prevalence – Selective Countries (in million cases)
USA32.5
UK4.0
Germany6.2
France4.0
Italy4.5
Spain5.2
Saudi Arabia4.4
UAE
1.0
DIABETES EPIDEMIOLOGY REPORT – KEY FINDINGS
Diagnosed Population
56.8%Undiagnosed Population
43.2%Population with Diabetes Types
Type 1
12,504,087 (4.4%)Type 2
269,376,970 (95.6%)Prevalence by Age Group
0–19 yrs
579,27620–44 yrs
46,553,35345–64 yrs
91,116,784>64 yrs
143,631,644Prevalence by Gender
Men
146,030,908 (51.8%)Women
135,850,149 (48.2%)Treatment Rate
48.9%Diagnosis Rate
56.8%Kidney Diseases Epidemiology
Conditions that impair the function of the kidneys, which are responsible for filtering waste and excess fluids from the blood, are known as kidney diseases. These diseases can range from acute kidney injury to chronic kidney disease (CKD), which may progress to kidney failure if not managed properly. Common causes include diabetes, high blood pressure, infections, and genetic disorders.
Globally, around 700 million people are estimated to be suffering from chronic kidney disease (CKD). Around 14% of adults in the U.S. are estimated to have CKD. Kidney diseases account for almost 2-4% of the total healthcare budgets in many developed nations. In the U.S., the annual cost of kidney diseases is estimated to be more than USD 85 billion.
Around 2 million people worldwide suffer from end-stage renal disease (ESRD), for which they receive dialysis or kidney transplants.
Patients Receiving Treatment for ESRD - Selective Countries
|
USA
|
750,000 |
|
Japan
|
350,000 |
|
Brazil
|
200,000 |
|
Germany
|
80,000 |
|
UK
|
70,000 |
Rare Diseases Epidemiology
A condition affecting less than 65 per 100,000 people is defined as a rare disease by the WHO. The global prevalence of more than 7,000 rare diseases together is around 300 million. More than 65% of the patients suffering from rare diseases are children and majority of these diseases do not have any treatment.
Prevalence of Selective Rare Diseases in the U.S.
| Cystic Fibrosis | Lou Gehrig's Disease (ALS) | Huntington's Disease | Duchenne Muscular Dystrophy (DMD) |
|---|---|---|---|
| 40,000 | 18,000 | 30,000 | 15,000 |
Cardiovascular Disease Epidemiology
Cardiovascular diseases (CVDs) are a group of disorders affecting the heart and blood vessels, including conditions like coronary artery disease, heart failure, stroke, and hypertension. They are the leading cause of death globally, often resulting from a combination of lifestyle factors and underlying health conditions.
It is estimated that around 60% of the U.S. adults will have some form of cardiovascular disease (CVD) in the next 30 years and the cost (direct and indirect) of CVD will be around USD 1.8 trillion. Globally, around 700 million people are living with CVDs and CVDs account for around one in three deaths every year.
Hypertension Prevalence – Selective Countries (in million cases)cardio
USA148
UK23
Germany31
France22
Italy22
Spain16
Saudi Arabia15
UAE
5
